These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26341513)

  • 1. Essential components in developing public policy to control viral hepatitis: lessons from Taiwan.
    Wallace J; Pitts M; Locarnini S; Ellard J; Carman M; Chen DS
    Hepatol Int; 2016 Mar; 10(2):355-62. PubMed ID: 26341513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
    Shiferaw F; Letebo M; Bane A
    BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia.
    Chen DS; Locarnini S; Wait S; Bae SH; Chen PJ; Fung JY; Kim HS; Lu SN; Sung J; Tanaka J; Wakita T; Ward J; Wallace J;
    J Hepatol; 2013 Nov; 59(5):1073-80. PubMed ID: 23850942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis c and human rights: comparison of legal experience of Ukraine and Georgia.
    Senyuta IY
    Wiad Lek; 2018; 71(2 pt 2):383-388. PubMed ID: 29786590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Nov; 61(RR-5):1-40. PubMed ID: 23135062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing HIV/AIDS, viral hepatitis, sexually transmitted disease, and tuberculosis prevention in the United States through program collaboration and service integration: the case for broader implementation.
    Steiner RJ; Aquino G; Fenton KA
    Sex Transm Dis; 2013 Aug; 40(8):663-8. PubMed ID: 23859918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting against viral hepatitis: lessons from Taiwan.
    Chen DS
    Hepatology; 2011 Aug; 54(2):381-92. PubMed ID: 21721025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between national viral hepatitis policies/programmes and country-level socioeconomic factors: a sub-analysis of data from the 2013 WHO viral hepatitis policy report.
    Lazarus JV; Sperle I; Safreed-Harmon K; Gore C; Cebolla B; Spina A
    BMC Public Health; 2017 Jul; 18(1):16. PubMed ID: 28743246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
    Chien YC; Jan CF; Kuo HS; Chen CJ
    Epidemiol Rev; 2006; 28():126-35. PubMed ID: 16782778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe.
    FitzSimons DW
    Vaccine; 2008 Oct; 26(45):5669-74. PubMed ID: 18762222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the eradication of hepatitis B in Taiwan.
    Wait S; Chen DS
    Kaohsiung J Med Sci; 2012 Jan; 28(1):1-9. PubMed ID: 22226055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance.
    Yang JR; Teng HJ; Liu MT; Li SY
    Health Secur; 2017; 15(2):154-164. PubMed ID: 28418742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hepatitis B virus infection by vaccination: the Taiwan experience.
    Lee SD; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Sep; 61(9):501-6. PubMed ID: 9798297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis: global goals for vaccination.
    Lavanchy D
    J Clin Virol; 2012 Dec; 55(4):296-302. PubMed ID: 22999800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach.
    Lemoine M; Eholié S; Lacombe K
    J Hepatol; 2015 Feb; 62(2):469-76. PubMed ID: 25457207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert Group Meeting on Family Planning, Health and Family Well-Being.
    Popul Bull UN; 1993; (34-35):79-101. PubMed ID: 12287717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs.
    Locarnini S; Hatzakis A; Chen DS; Lok A
    J Hepatol; 2015 Apr; 62(1 Suppl):S76-86. PubMed ID: 25920093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.